News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Amello Jason
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/02/2023 |
4
| Amello Jason (CFO) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 90,000 options to buy
@ $1.29, valued at
$116.1k
|
|
| 03/16/2023 |
4
| Amello Jason (Director) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.67, valued at
$33.4k
|
|
| 12/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2022 |
4
| Amello Jason (CFO) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 230,000 options to buy
@ $3.21, valued at
$738.3k
|
|
| 09/23/2022 |
3
| Amello Jason (CFO) has filed a Form 3 on Candel Therapeutics, Inc. |
| 01/19/2022 |
4
| Amello Jason (Director) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 18,500 options to buy
@ $2.21, valued at
$40.9k
|
|
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2018 |
4
| Amello Jason (SVP, CFO & Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 22,235 shares
@ $8.94, valued at
$198.8k
|
|
| 03/02/2018 |
4
| Amello Jason (SVP, CFO & Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 19,500 shares
@ $0
Granted 27,700 options to buy
@ $14.3, valued at
$396.1k
|
|
| 10/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/23/2017 |
4
| Amello Jason (SVP, CFO & Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc. |
| 02/24/2016 |
4
| Amello Jason (SVP, CFO & Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 26,000 shares
@ $0
Granted 39,650 options to buy
@ $7.7, valued at
$305.3k
|
|
| 03/10/2015 |
4
| Amello Jason (SVP, CFO & Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 45,000 options to buy
@ $11.15, valued at
$501.8k
|
|
| 12/01/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/05/2014 |
4
| Amello Jason (SVP, CFO & Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 21,667 options to buy
@ $22.8, valued at
$494k
|
|
| 03/27/2014 |
4
| Amello Jason (SVP, CFO & Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Bought 4,000 shares
@ $17, valued at
$68k
|
|
| 05/14/2013 |
4
| Amello Jason (Executive Vice President & CFO) has filed a Form 4 on ZIOPHARM ONCOLOGY INC|
Txns:
| Paid exercise price by delivering 2,623 shares
@ $1.65, valued at
$4.3k
|
|
| 01/03/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/10/2012 |
4
| Amello Jason (Executive Vice President & CFO) has filed a Form 4 on ZIOPHARM ONCOLOGY INC|
Txns:
| Granted 25,000 shares
@ $0 |
|
| 05/10/2012 |
3
| Amello Jason (Executive Vice President & CFO) has filed a Form 3 on ZIOPHARM ONCOLOGY INC |
| 04/06/2011 |
4
| Amello Jason (CorpContrllr,ChiefAccntOfficer) has filed a Form 4 on GENZYME CORP|
Txns:
| Unknown transaction of 2,084 shares
@ $74, valued at
$154.2k
Disposed/sold 5,005 shares
@ $74, valued at
$370.4k
Exercised 1,818 restricted stock units
@ $0
Exercised 1,740 restricted stock units
@ $0
Exercised 1,447 restricted stock units
@ $0
Disposed/sold 4,340 options to buy
@ $51.52, valued at
$223.6k
Disposed/sold 5,455 options to buy
@ $58.66, valued at
$320k
Disposed/sold 5,220 options to buy
@ $68.48, valued at
$357.5k
Disposed/sold 4,725 options to buy
@ $62.16, valued at
$293.7k
Disposed/sold 8,640 options to buy
@ $58.5, valued at
$505.4k
Disposed/sold 9,300 options to buy
@ $62.98, valued at
$585.7k
|
|
| 02/10/2011 |
5
| Amello Jason (CorpContrllr,ChiefAccntOfficer) has filed a Form 5 on GENZYME CORP |
| 09/02/2010 |
4
| Amello Jason (Corp Contrllr,ChiefAccntOfficr) has filed a Form 4 on GENZYME CORP|
Txns:
| Sold 6,640 shares
@ $70.3, valued at
$466.8k
Exercised 6,640 options to buy
@ $46.24, valued at
$307k
|
|
| 06/18/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/26/2010 |
4
| Amello Jason (CorpContrllr,ChiefAccntOfficer) has filed a Form 4 on GENZYME CORP|
Txns:
| Sold 533 shares
@ $45.62, valued at
$24.3k
Exercised 1,575 restricted stock units
@ $0 |
|
| 05/26/2009 |
4
| Amello Jason (CorpContrllr,ChiefAccntOfficer) has filed a Form 4 on GENZYME CORP |
| 01/06/2009 |
3/A
| Amello Jason (CorpContrllr,ChiefAccntOfficer) has filed a Form 3/A on GENZYME CORP |
| 12/10/2008 |
3
| Amello Jason (CorpContrllr,ChiefAccntOfficer) has filed a Form 3 on GENZYME CORP |
|
|